Atara Biotherapeutics, Inc. (ATRA) Social Stream



Atara Biotherapeutics, Inc. (ATRA): $4.94

-0.40 (-7.49%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ATRA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 404

in industry

Atara Biotherapeutics Inc (ATRA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Atara Biotherapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 7 $31 $26 $27.8 $9.3 198.92%
2021-12-09 7 $31 $26 $28 $9.3 201.08%
2021-12-13 6 $31 $26 $28 $9.3 201.08%
2021-12-15 5 $31 $24 $27.25 $9.3 193.01%
2022-01-24 5 $31 $24 $27.5 $9.3 195.7%
2022-01-26 5 $31 $25 $27.75 $9.3 198.39%
2022-02-23 5 $31 $25 $27 $9.3 190.32%
2022-03-01 5 $31 $20 $25.75 $9.3 176.88%

The Trend in the Analyst Price Target


Over the past 178 days, ATRA's average price target has gone down $7.63.

ATRA reports an average of 126.24% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-17 6 78 10 35.57 13.28 167.85%
2021-05-22 11 78 10 35.29 13.77 156.28%
2021-08-14 11 78 10 35.00 12.45 181.12%
2021-12-15 5 31 24 27.25 16.03 69.99%
2022-01-14 5 31 24 27.50 16.07 71.13%

ATRA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 151 days, ATRA's average broker recommendation rating improved by 0.82.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ATRA as an investment opportunity.

  • Atara Biotherapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 789.24% of all US stocks.
  • In the context of all US stocks, Atara Biotherapeutics Inc's variance in analysts' estimates is lower than -161.62% of them.
  • In terms of how Atara Biotherapeutics Inc fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 649.99% of that group.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Atara Biotherapeutics Inc's average analyst price target is higher than 562.28% of them.

Stocks similar to Atara Biotherapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ATHA, APTO, and AMAM.

Is ATRA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4395 seconds.